Skip to content

Kaltura, Inc. KLTR Pending proceeds from option exercises

Pending proceeds from option exercises at other companies

Microbot Medical logo
Microbot MedicalMBOT
$250
KDK
Kodiak AI, Inc. Common StockKDK
$1K-99.2%
Opus Genetics logo
Opus GeneticsIRD
$738K+14,660%
AeroVironment logo
AeroVironmentAVAV
$460.25K
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$8.98M+176,722%
American Superconductor logo
American SuperconductorAMSC
$149K-0.7%

Other financials

Income statement

See full
Revenue$44.6M-5.0%
Gross profit$32.1M-1.9%
Operating income-$1.2M+22.4%
Net income-$3.8M-237%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$58.5M+84.0%
Total debt$72.3M+49.0%
Total equity$4.6M-79.5%
Total assets$159.8M-7.5%

Cash flow

See full
Operating cash flow$656.0K+163%
CapEx$61.0K-79.5%
Free cash flow$595.0K+144%

Valuation

See full
Market cap$189.47M-37.1%
Enterprise value$203.31M-35.3%
P/S1.1×-0.6×

Profitability

See full
Gross margin71.2%+3.1pp
Operating margin-5.3%-2.1pp
Net margin-8.2%-1.9pp
FCF margin8.9%+2.4pp

Returns & leverage

See full
Return on equity-107.8%+28.3pp
Debt / equity15.6×+13.4×
Current ratio0.8×-0.3×

Where this comes from

Reported directly by Kaltura, Inc. in its filing.

Tagged under the XBRL concept kltr:PendingProceedsFromOptionExercises.

The official record: Kaltura, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kaltura, Inc.'s pending proceeds from option exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kaltura, Inc.'s pending proceeds from option exercises?
Kaltura, Inc. (KLTR) reported pending proceeds from option exercises of $21K in Q1 2026.
How has Kaltura, Inc.'s pending proceeds from option exercises changed year-over-year?
Kaltura, Inc.'s pending proceeds from option exercises increased by 61.5% year-over-year, from $13K to $21K.
What does pending proceeds from option exercises mean?
This metric represents the value of cash proceeds expected from the exercise of employee or director stock options that have been granted but not yet settled. It serves as a forward-looking indicator of potential liquidity inflows from equity-based compensation plans. Investors monitor this to assess the potential impact of future share dilution and the associated cash infusion into the company's capital structure.